IFNL3 and chronic hepatitis B virus infection: Second, IFN therapy inhibits hepatic carcinogenesis in patients with chronic hepatitis B[15], this indicates that IL-28B with mutation type can’t function normally, they can’t inhibits carcinogenesis effectively, and resulted in malignant progress and outcome.